secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001193125-25-033463
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin appoints Timothy Walbert to board, expanding size to 12 members
------------------------------------------------------------------------

- Board increased from 11 to 12 members; Walbert appointed effective February 24, 2025.
- Walbert receives standard independent director compensation including pro rata RSU grant (annual award $400,000).
- No committee assignments at this time; standard indemnification agreement to be entered into.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312525033463/0001193125-25-033463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312525033463/d876806d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-033463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer